Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.35 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1404022 | 0.97 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| Hydrochloric Acid SCHEMBL11579673 | 0.97 | SMN1; SMN2 (0.43) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL1404113 | 0.97 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL3922842 | 0.97 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL1404088 | 0.97 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL8613055 | 0.97 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL1404042 | 0.97 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL8616701 | 0.97 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL1404074 | 0.97 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL8612471 | 0.97 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4667511-A2 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | Tiba Biotech LLC (US) | 2025-12-24 | — | — | EP | claimed |
| EP-4190882-B1 | QUATERNISED NITROGEN COMPOUNDS SUBSTITUTED WITH HYDROCARBYL-POLYCARBOXYLIC ACID AND ALKYLENE OXIDE AS ADDITIVES IN FUELS | BASF SE (DE) | 2024-12-25 | — | — | EP | claimed |
| EP-4442792-A2 | USE WITH ALKYLENE OXIDE AND HYDROCARBYL-SUBSTITUTED POLYCARBOXYLIC ACID OF QUATERNISED NITROGEN COMPOUNDS AS ADDITIVES IN FUELS AND LUBRICANTS | BASF SE (DE) | 2024-10-09 | — | — | EP | claimed |
| US-20240207187-A1 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | TIBA BIOTECH LLC (US) | 2024-06-27 | — | — | US | claimed |
| CN-117915958-A | Dendritic structures as non-viral vectors in gene delivery | 蒂巴生物技术有限公司 | 2024-04-19 | — | — | CN | claimed |
| US-11912950-B2 | Use of nitrogen compounds quaternised with alkylene oxide and hydrocarbyl-substituted polycarboxylic acid as additives in fuels and lubricants | BASF SE (DE) | 2024-02-27 | — | — | US | claimed |
| EP-4313170-A1 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | Tiba Biotech LLC (US) | 2024-02-07 | — | — | EP | claimed |
| EP-3381998-B1 | QUATERNARY AMMONIUM ESTER SALTS | LUBRIZOL CORP (US) | 2023-08-23 | — | — | EP | claimed |
| EP-4190882-A1 | USE WITH ALKYLENE OXIDE AND HYDROCARBYL-SUBSTITUTED POLYCARBOXYLIC ACID OF QUATERNISED NITROGEN COMPOUNDS AS ADDITIVES IN FUELS AND LUBRICANTS | BASF SE (DE) | 2023-06-07 | — | — | EP | claimed |
| CN-116120714-A | Preparation method and application of epoxy resin-based prepreg | 万华化学（北京）有限公司 | 2023-05-16 | — | — | CN | claimed |
| US-20030087981-A1 | Floor finish compositions | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-08 | — | — | US | claimed |
| WO-2003008409-A1 | QUINOLINE DERIVATIVES AND THEIR USE AS TYROSINE KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2003-01-30 | — | — | WO | claimed |
| WO-2002085895-A1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2002-10-31 | — | — | WO | claimed |
| WO-2002030926-A1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2002-04-18 | — | — | WO | claimed |
| WO-2002030924-A1 | QUINAZOLINE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY | ASTRAZENECA AB (SE) | 2002-04-18 | — | — | WO | claimed |
| WO-2002016352-A1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2002-02-28 | — | — | WO | claimed |
| US-6197844-B1 | Floor finish compositions | 3M INNOVATIVE PROPERTIES COMPANY | 2001-03-06 | — | — | US | claimed |
| CN-1229423-A | Floor finish compositions | MINNESOTA MINING & MFG (US) | 1999-09-22 | — | — | CN | claimed |
| EP-0122151-B1 | PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1989-02-15 | — | — | EP | claimed |
| US-3984382-A | AMINO ALCOHOLS, DIFUNCTIONAL AMINES, MONOEPOXIDE | AMERICAN CYANAMID COMPANY (US) | 1976-10-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240207187-A1 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | TLR3, TLR9, TLR6 | SMN1; SMN2 2284/4885ALDH1A1 3862/4885LMNA 735/4885 |
| US-11912950-B2 | Use of nitrogen compounds quaternised with alkylene oxide and hydrocarbyl-substituted polycarboxylic acid as additives in fuels and lubricants | DGKI, DERL1, DEK | SMN1; SMN2 3109/4885ALDH1A1 3085/4885LMNA 1187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.